Edesa Biotech, Inc. Quarterly Current Ratio in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Edesa Biotech, Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q2 2024.
  • Edesa Biotech, Inc. Current Ratio for the quarter ending June 30, 2024 was 230 %, a 54.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 230 -280 -54.9% Jun 30, 2024
Q1 2024 307 -82.5 -21.2% Mar 31, 2024
Q4 2023 390 -24.1 -5.82% Dec 31, 2023
Q3 2023 493 +88.3 +21.8% Sep 30, 2023
Q2 2023 510 +57.7 +12.8% Jun 30, 2023
Q1 2023 390 -332 -46% Mar 31, 2023
Q4 2022 414 -242 -36.9% Dec 31, 2022
Q3 2022 405 -292 -41.9% Sep 30, 2022
Q2 2022 452 -189 -29.4% Jun 30, 2022
Q1 2022 722 +182 +33.7% Mar 31, 2022
Q4 2021 655 -80.4 -10.9% Dec 31, 2021
Q3 2021 697 -3.53 -0.5% Sep 30, 2021
Q2 2021 641 -243 -27.5% Jun 30, 2021
Q1 2021 540 -367 -40.4% Mar 31, 2021
Q4 2020 736 -105 -12.4% Dec 31, 2020
Q3 2020 700 -256 -26.8% Sep 30, 2020
Q2 2020 884 -255 -22.4% Jun 30, 2020
Q1 2020 907 -807 -47.1% Mar 31, 2020
Q4 2019 840 -941 -52.8% Dec 31, 2019
Q3 2019 956 -599 -38.5% Sep 30, 2019
Q2 2019 1.14K -352 -23.6% Jun 30, 2019
Q1 2019 1.71K +416 +32% Mar 31, 2019
Q4 2018 1.78K +77.4 +4.54% Dec 31, 2018
Q3 2018 1.55K -399 -20.4% Sep 30, 2018
Q2 2018 1.49K -436 -22.6% Jun 30, 2018
Q1 2018 1.3K -293 -18.4% Mar 31, 2018
Q4 2017 1.7K +244 +16.7% Dec 31, 2017
Q3 2017 1.95K +590 +43.2% Sep 30, 2017
Q2 2017 1.93K +1.14K +144% Jun 30, 2017
Q1 2017 1.59K +883 +125% Mar 31, 2017
Q4 2016 1.46K +924 +172% Dec 31, 2016
Q3 2016 1.36K +956 +234% Sep 30, 2016
Q2 2016 790 +257 +48.2% Jun 30, 2016
Q1 2016 709 Mar 31, 2016
Q4 2015 536 Dec 31, 2015
Q3 2015 409 Sep 30, 2015
Q2 2015 533 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.